期刊文献+

老年慢性心力衰竭的临床特点及药物治疗回顾性分析 被引量:38

Analysis of Clinical Characteristic and Drug Therapy in Elderly Chronic Heart Failure Patients
原文传递
导出
摘要 目的分析老年慢性心力衰竭住院患者的临床特点及药物治疗情况,为老年慢性心力衰竭患者的临床药物治疗提供依据。方法回顾性分析2013年10月至2014年10月北京大学人民医院心内科普通病房的慢性心力衰竭患者共68例。根据年龄分为老年组和非老年组,收集患者的相关临床基线资料和出院时药物治疗情况。结果与非老年组相比,老年组慢性心力衰竭患者病情相对较重、肝肾功能减退、血钠偏低、β受体阻滞剂达到目标剂量的人数相对较少、联合用药情况较多。结论临床上应加强对老年慢性心力衰竭患者的关注,结合老年慢性心衰患者的病情特点慎重选择药物治疗,同时注意药物的不良反应和相互作用,加强指导,以改善患者预后。 OBJECTIVE To investigate the clinical characters and the situation of oral drug therapy in elderly chronic heart failure patients. METHODS The survey was conducted among 68 chronic heart failure patients who were hospitalized between October2013 and October 2014 in Peking university people’ s hospital. Data were collected and statistically analyzed concerning the clinical characters and the oral drug therapy between the elderly and non-elderly groups. RESULTS Worsening of heart function was more significantly in the elderly chronic heart failure group than the non-elderly group. There was a tendency of multiorgan statement represented by hepatic and renal function to decrease with age. Both the level of serum and the percentage of those proper for beta blocker arrived to the minimal target dose were lower in the elderly group than in the matched group. Combined treatment of different drug was more common in the elderly group. CONCLUSION The physiological functions of elderly patients decreased and the patients often had many concomitant disease. It is very important to pay more attention to drug selections,drug interactions and adverse reactions to optimize the treatment plan to improve the quality of life and the prognosis of these elderly chronic heart failure patients according their clinical characters.
出处 《中国药学杂志》 CAS CSCD 北大核心 2015年第10期901-904,共4页 Chinese Pharmaceutical Journal
关键词 老年 慢性心力衰竭 临床特点 药物治疗 elderly chronic heart failure clinical character drug therapy
  • 相关文献

参考文献16

  • 1PAN H Y, ZHU J H, GU Y, et al. Comparative effects of recom- binant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with different blood BNP lev- els[Jl. BMC Cardiovasc Disord, 2014, 14(2) :31. 被引量:1
  • 2SCHULZE P C, JIANG J, YANG J, et al. Preoperative assess- ment of high risk candidates to predict survival after heart trans- plantation []1. Circ Heart Fail, 2013,6(3) :527-534. 被引量:1
  • 3Chinese Society of Cardiology, Editorial. Board of Chinese Journal of Cardiology. Chinese guidelines for the diagnosis and treatmentofheartfailure2014[J].中华心血管病杂志,2014,42(2):98-122. 被引量:1
  • 4GUSTAFSSON F, TORP-PEDERSEN C, SE1BAEK M, et al. Effect of age on short and long-term mortality in patients admitted to hospi- tal with congestive heart failure [ J ]. Eur Heart J, 2004, 25 (19) : 1711-1717. 被引量:1
  • 5LEVY D, KENCHAIAH S, LARSON M G, et al. Long-termtrends in the incidence of and survival with heart failure [ J ]. N Engl J Med,2002,347 (18 ) : 1397-1402. 被引量:1
  • 6VELAVAN P,KHAN N K, GOODE K, et al. Predictors of short term mortality in heart failure -insights from the Euro Heart Fail- ure survey [J]. lnt J Cardiol,2010, 138( 1 ) : 63-69. 被引量:1
  • 7BUI A L, HORWICH T B, FONAROW G C. Epidemiology and risk profile of heart failure [ J]. Nat Rev Cardiol, 2011,8 ( 1 ) : 30-41. 被引量:1
  • 8CHEN X Q, JIN Y Y, TANG G. New Pharmacology [ M ]. Beijing: People' s Medical Publishing House, 2011 : 15, 55. 被引量:1
  • 9ALLEN L A, FELKER G M, POCOCK S, et al. Liver function abnormalities and outcome in patients with chronic heart failure: Data from the Candesartan in Heart Failure: Assessment of Re- duction in Mortality and Morbidity (CHARM) program [ Jl. Eur J Heart Fail, 2009, 11(2) : 170-177. 被引量:1
  • 10NOHRIA A, HASSELBLAD V, STEBBINS A, et al. Cardiorenal interactions: Insights from the ESCAPE trial [J ]. J Am CoU Car- diol, 2008, 51(13): 1268-1274. 被引量:1

二级参考文献10

共引文献13

同被引文献281

引证文献38

二级引证文献350

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部